Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 3226 AL 3240

Effect of Exercise and Oral Niacinamide Mononucleotide on Improving Mitochondrial Autophagy in Alzheimer's Disease

Wu W, Yuan S, Tang Y, Meng X, Peng M, Hu Z, Liu W.

Nutrients. 2023 Jun 23;15(13):2851. doi: 10.3390/nu15132851.

A Triterpenoid Lupeol as an Antioxidant and Anti-Neuroinflammatory Agent: Impacts on Oxidative Stress in Alzheimer's Disease

Park JS, Rehman IU, Choe K, Ahmad R, Lee HJ, Kim MO.

Nutrients. 2023 Jul 7;15(13):3059. doi: 10.3390/nu15133059.

The potential of psychedelics for the treatment of Alzheimer's disease and related dementias

Winkelman MJ, Szabo A, Frecska E.

Eur Neuropsychopharmacol. 2023 Nov;76:3-16. doi: 10.1016/j.euroneuro.2023.07.003. Epub 2023 Jul 12.

Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation

Chen Y, Yu Y.

J Neuroinflammation. 2023 Jul 14;20(1):165. doi: 10.1186/s12974-023-02853-3.

Selective neuronal vulnerability to deficits in RNA processing

Zuniga G, Frost B.

Prog Neurobiol. 2023 Oct;229:102500. doi: 10.1016/j.pneurobio.2023.102500. Epub 2023 Jul 16.

Ushering in a New Era of Alzheimer Disease Therapy

Widera EW, Brangman SA, Chin NA.

JAMA. 2023 Aug 8;330(6):503-504. doi: 10.1001/jama.2023.11701.

Amyloid-Targeting Monoclonal Antibodies for Alzheimer Disease

Rabinovici GD, La Joie R.

JAMA. 2023 Aug 8;330(6):507-509. doi: 10.1001/jama.2023.11703.

Novel Alzheimer Disease Treatments and Reconsideration of US Pharmaceutical Reimbursement Policy

Rosenthal MB.

JAMA. 2023 Aug 8;330(6):505-506. doi: 10.1001/jama.2023.11702.

A critical review on the role of nanotheranostics mediated approaches for targeting β amyloid in Alzheimer's

Rastogi V, Jain A, Kumar P, Yadav P, Porwal M, Chaturvedi S, Chandra P, Verma A.

J Drug Target. 2023 Aug;31(7):725-744. doi: 10.1080/1061186X.2023.2238250. Epub 2023 Jul 19.

Autonomic nervous system flexibility for understanding brain aging

Lin FV, Heffner KL.

Ageing Res Rev. 2023 Sep;90:102016. doi: 10.1016/j.arr.2023.102016. Epub 2023 Jul 17.

Signal Pathways and Intestinal Flora through Trimethylamine N-oxide in Alzheimer's Disease

Zhang Y, Jian W.

Curr Protein Pept Sci. 2023;24(9):721-736. doi: 10.2174/1389203724666230717125406.

Exploring New Vista for Alzheimer's Disease Drug Targets (Part II)

Bolinger AA, Zhou J.

Curr Top Med Chem. 2023;23(13):1211-1213. doi: 10.2174/156802662313230626121232.

Natural antioxidants that act against Alzheimer's disease through modulation of the NRF2 pathway: a focus on their molecular mechanisms of action

Sidiropoulou GA, Metaxas A, Kourti M.

Front Endocrinol (Lausanne). 2023 Jul 3;14:1217730. doi: 10.3389/fendo.2023.1217730. eCollection 2023.

Integration of genome-wide association studies (GWAS) and microbiome data highlights the impact of sulfate-reducing bacteria on Alzheimer's disease

Guo X, Zhang X, Tang P, Chong L, Li R.

Age Ageing. 2023 Jul 1;52(7):afad112. doi: 10.1093/ageing/afad112.

Targeted Regulation of Intracellular Signal Transduction: A New Paradigm for Stimulation of Neurogenesis in Alzheimer's Disease

Zyuz'kov G.

Curr Drug Targets. 2023;24(10):777-780. doi: 10.2174/1389450124666230719104808.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias